{"altmetric_id":5046769,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["CurrentIncurSci"],"posts_count":1}},"selected_quotes":["@PDRennert New CRC, TNB, Panc bifunctionl DART in clinic?(90% confidence level, not 100%):PF-06671008 (NCT02659631)."],"citation":{"altmetric_jid":"4f6fa6103cf058f610006dd4","authors":["Timothy S. Fisher","Adam Root","Bryan Peano","Allison Rohner","Justin Lucas","Mark Elliott","Konstantinos Tsaparikos","Hui Wang","Jonathan Golas","Maria Gavriil","Susan Benard","Tao He","Tracey Clark","Nahor Haddish-Berhane","Ralph Alderson","Yinhua Yang","Syd Johnson","Paul Moore","Lioudmila Tchistiakova","Hans-Peter Gerber","Chad May"],"doi":"10.1158\/1538-7445.am2015-2476","endpage":"2476","first_seen_on":"2016-01-27T04:38:04+00:00","issns":["1538-7445"],"issue":"15 Supplement","journal":"Cancer Research","last_mentioned_on":1453869466,"links":["http:\/\/cancerres.aacrjournals.org\/content\/75\/15_Supplement\/2476.abstract?cited-by=yes&legid=canres;75\/15_Supplement\/2476"],"pubdate":"2015-08-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"2476","subjects":["neoplasms"],"title":"Abstract 2476: Bispecific redirected T-cell immunotherapy targeting P-cadherin expressing tumors","type":"article","volume":"75"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":7054473,"mean":6.2693339663096,"rank":3511050,"this_scored_higher_than_pct":28,"this_scored_higher_than":2033178,"rank_type":"exact","sample_size":7054473,"percentile":28},"similar_age_3m":{"total_number_of_other_articles":318613,"mean":9.2533167677297,"rank":166053,"this_scored_higher_than_pct":37,"this_scored_higher_than":117952,"rank_type":"exact","sample_size":318613,"percentile":37},"this_journal":{"total_number_of_other_articles":6671,"mean":6.6634110944528,"rank":4370,"this_scored_higher_than_pct":20,"this_scored_higher_than":1351,"rank_type":"exact","sample_size":6671,"percentile":20},"similar_age_this_journal_3m":{"total_number_of_other_articles":435,"mean":17.061105990783,"rank":330,"this_scored_higher_than_pct":17,"this_scored_higher_than":78,"rank_type":"exact","sample_size":435,"percentile":17}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/CurrentIncurSci\/statuses\/692204830291542016","license":"gnip","citation_ids":[5046769],"posted_on":"2016-01-27T04:37:46+00:00","author":{"name":"Tom Marsilje","url":"http:\/\/fightcolorectalcancer.org\/category\/research-treatment\/currently-incurable-scientist\/","image":"https:\/\/pbs.twimg.com\/profile_images\/861194803031162880\/2wf_3Lwn_normal.jpg","description":"http:\/\/adventuresinlivingterminallyoptimistic.com\/ I work for Novartis. All tweets, posts & blog writings are my own private opinion.","id_on_source":"CurrentIncurSci","tweeter_id":"3293238126","geo":{"lt":null,"ln":null},"followers":972},"tweet_id":"692204830291542016"}]}}